Global Organ-On-Chip Market Analysis & Trends - Industry Forecast to 2030

Global Organ-On-Chip Market Analysis & Trends - Industry Forecast to 2030

Organ-On-Chip: Market Size

From $158.78 million in 2024, the global Organ-On-Chip market is projected to reach $1031.6 million by 2030. Based on our analysis the market is expected to grow at a CAGR of 36.6% from 2024 - 2030 timeframe. Some of the prominent trends that the market is witnessing include technological advancements and new products launches, increasing focus on drug discovery activities, and growing initiatives to increase awareness about organs-on-chips technologies.

Global Organ-On-Chip Market: Market Dynamics

An organ-on-a-chip is a microfluidic cell culture tool that contains constantly perfused chambers. This chip develops a narrow channel for the blood and airflow in organs, such as the liver, heart, lung, gut, and other organs. Such devices create multiple levels of tissue and organ functionalities, which are not sufficient using conventional 2D and 3D culture systems. It offers a broad range of applications, such as patient stratification, disease modeling, and phenotypic screening.

Surge in applications of organ-on-chip (OOC) devices in the healthcare sector, nascent stage of R&D pertaining to OOCs, rise in in demand for OOCs for lung- & kidney-based organ culture, increase in demand for organ-on-chip in drug screening, high cost of OOC devices, and increase in research activities on OOC devices are the significant factors that impact the global organ-on-chip market growth.

On the other hand, issues pertaining to the incorporation of organ-on-chips technologies into the existing workflows are likely to obstruct the profit boundaries. In addition, growing focus on developing alternatives for animal testing models and growing number of partnerships and collaborations between pharmaceutical companies and organs-on-chips manufacturers will further boost the organ-on-chip market.

Impact of COVID-19 on Organ-On-Chip

The outbreak of COVID-19 in the major economies of these regions such as the China and US, Japan has optimistically impacted the market growth. To control the spreading of COVID-19 among the world's population the scientists and researchers have been using organ-on-chips for drug innovation for the vaccination and to understand immune responses against SARS-CoV-2. In Oct 2020, the Food and Drug Administration (FDA) had utilized organ-on-chip models to test mechanisms for preventing COVID-19 infections, and other processes. The FDA used Emulate Inc's organ-on-chip models for this procedure under a cooperative research agreement. During the COVID-19 pandemic, the use of lung-on-chips was improved for the research and development of drugs to recover the lung infection caused by the virus. These factors affected the growth of the market positively.

By Type

Lung-On-Chip Segment Dominate the Market in 2024

The lung-on-chip segment made huge revenue in 2024 and growing its prominence during the forecast period. The lung-on-chip technology is a compound, three-dimensional model of a living, breathing human lung on a microchip. This device, prepared up of human lung and blood vessel cells, can expect the absorption of airborne nanoparticles and mimic the inflammatory response triggered by microbial pathogens. With the arrangement of the microfabrication techniques, with modern tissue engineering, lung-on-chip also offers a new in vitro approach to drug screening by mimicking the complicated mechanical and biochemical behaviors of a human lung.

By Geography

Asia Pacific Region is Leading in the Global Market Place

The Asia Pacific is likely to have a huge demand in the forecast period. The increase in disposable income of the population is expected to increase the adoption of organ-on-chip technology in the region. The government funding for regenerative medicines in research institutions, along with a growing number of cell-based clinical trials and investment in R&D activities, is estimated to increase the growth of the organ-on-chip market size in this region.

List of the Key Players Profiled in the Market Include:

• Cherry Biotech SAS
• CN Bio Innovations
• Draper Laboratory
• Else Kooi Laboratory
• Emulate
• Hesperos
• Kirkstall
• Micronit Microtechnologies B.V.
• Mimetas
• Nortis
• Tara Biosystems
• TissUse
• F. Hoffmann-La Roche Ltd
• Organovo Holdings, Inc.
• BiomimX SRL
• SynVivo, Inc.
• MIMETAS B.V.
• InSphero AG
• AxoSim, Inc
• uFluidix Inc

List of the Regions/Countries Profiled in the Market Include:

North America
• US
• Canada
• Mexico
Europe
• Germany
• U.K
• Italy
• France
• Spain
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• New Zealand
• Rest of Asia Pacific
Middle East
• Saudi Arabia
• UAE
• Rest of Middle East
Latin America
• Argentina
• Brazil
• Rest of Latin America
Rest of the World (RoW)
• South Africa
• Others